MMP2 and hepatocellular carcinoma: By directly targeting the matrix metalloproteinase-2 (MMP-2) expression, miR-29b has been shown to suppress angiogenesis, invasion, and metastasis of HCC in animal model and confirmed in clinical samples [33].